Surgical Science Sweden AB(SE:SUS)
kr 58.50+1.10 (+1.92%)
SE:SUS
Surgical Science Sweden AB financials statements
kr 58.50
At close:+1.10 (+1.92%)
Want to see SE:SUS full AI Analyst Report?
Surgical Science Sweden AB (SUS) Ratios
5 Followers
Surgical Science Sweden AB Ratios
SE:SUS's free cash flow for Q3 2026 was kr27.62M. For the 2026 fiscal year, SE:SUS's free cash flow was decreased by kr-14.90M and operating cash flow was kr42.52M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.07 | 2.78 | 4.22 | 2.70 | 2.65 |
| Quick Ratio | 3.36 | 2.43 | 3.56 | 2.26 | 2.17 |
| Cash Ratio | 2.12 | 1.89 | 2.70 | 1.42 | 1.36 |
| Solvency Ratio | 0.36 | 0.30 | 0.81 | 0.56 | 0.29 |
| Operating Cash Flow Ratio | 0.27 | 0.27 | 1.01 | 0.42 | 0.17 |
| Short-Term Operating Cash Flow Coverage | 3.55 | 7.36 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr 766.37M | kr 774.97M | kr 633.73M | kr 413.26M | kr 223.85M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.02 | 0.05 | 0.01 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.02 | 0.06 | 0.01 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.02 | 0.06 | 0.01 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.05 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.10 | 1.13 | 1.08 | 1.10 | 1.11 |
| Debt Service Coverage Ratio | 5.53 | 8.13 | 442.44 | 192.41 | 5.90 |
| Interest Coverage Ratio | 17.34 | 25.41 | 288.34 | 124.55 | 3.87 |
| Debt to Market Cap | 0.01 | 0.03 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 1.67 | 5.84 | 0.80 | 0.31 | 0.82 |
| Net Debt to EBITDA | -2.79 | -3.01 | -1.83 | -1.54 | -2.65 |
| Profitability Margins | |||||
| Gross Profit Margin | 58.14% | 67.63% | 69.42% | 66.23% | 72.51% |
| EBIT Margin | 10.98% | 18.52% | 30.46% | 28.37% | 24.20% |
| EBITDA Margin | 19.38% | 25.37% | 36.76% | 33.80% | 31.37% |
| Operating Profit Margin | 10.98% | 16.32% | 21.43% | 20.25% | 24.20% |
| Pretax Profit Margin | 10.09% | 17.88% | 30.39% | 25.94% | 17.94% |
| Net Profit Margin | 6.73% | 14.89% | 26.50% | 23.42% | 23.52% |
| Continuous Operations Profit Margin | 6.73% | 14.89% | 26.50% | 23.42% | 23.52% |
| Net Income Per EBT | 66.73% | 83.27% | 87.22% | 90.30% | 131.07% |
| EBT Per EBIT | 91.89% | 109.54% | 141.82% | 128.08% | 74.14% |
| Return on Assets (ROA) | 1.42% | 2.40% | 4.98% | 4.04% | 2.17% |
| Return on Equity (ROE) | 1.56% | 2.73% | 5.38% | 4.44% | 2.41% |
| Return on Capital Employed (ROCE) | 2.48% | 2.91% | 4.23% | 3.74% | 2.37% |
| Return on Invested Capital (ROIC) | 1.64% | 2.41% | 3.69% | 3.38% | 2.37% |
| Return on Tangible Assets | 5.17% | 8.48% | 21.52% | 20.79% | 12.59% |
| Earnings Yield | 4.03% | 1.65% | 2.52% | 2.25% | 0.72% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.43 | 3.42 | 7.98 | 3.29 | 2.04 |
| Payables Turnover | 11.46 | 4.90 | 6.54 | 4.13 | 2.93 |
| Inventory Turnover | 2.02 | 1.59 | 1.75 | 2.01 | 0.89 |
| Fixed Asset Turnover | 9.33 | 8.71 | 11.52 | 15.63 | 9.55 |
| Asset Turnover | 0.21 | 0.16 | 0.19 | 0.17 | 0.09 |
| Working Capital Turnover Ratio | 1.10 | 1.06 | 1.38 | 1.77 | 1.51 |
| Cash Conversion Cycle | 255.50 | 261.07 | 198.72 | 204.21 | 463.93 |
| Days of Sales Outstanding | 106.38 | 106.58 | 45.73 | 111.03 | 178.92 |
| Days of Inventory Outstanding | 180.97 | 229.04 | 208.81 | 181.65 | 409.42 |
| Days of Payables Outstanding | 31.85 | 74.54 | 55.82 | 88.47 | 124.40 |
| Operating Cycle | 287.35 | 335.61 | 254.54 | 292.68 | 588.34 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.56 | 2.69 | 4.68 | 2.55 | 0.92 |
| Free Cash Flow Per Share | 1.33 | 1.76 | 3.81 | 1.87 | 0.58 |
| Dividend Paid and CapEx Coverage Ratio | 6.83 | 2.89 | 5.40 | 3.75 | 2.72 |
| Capital Expenditure Coverage Ratio | 6.83 | 2.89 | 5.40 | 3.75 | 2.72 |
| Operating Cash Flow Coverage Ratio | 1.01 | 0.47 | 5.95 | 8.82 | 3.24 |
| Operating Cash Flow to Sales Ratio | 0.08 | 0.16 | 0.27 | 0.16 | 0.11 |
| Free Cash Flow Yield | 4.11% | 1.13% | 2.09% | 1.13% | 0.21% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 24.81 | 60.43 | 39.73 | 44.51 | 138.68 |
| Price-to-Sales (P/S) Ratio | 1.67 | 9.00 | 10.53 | 10.43 | 32.61 |
| Price-to-Book (P/B) Ratio | 0.39 | 1.65 | 2.14 | 1.97 | 3.34 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 24.35 | 88.69 | 47.87 | 88.13 | 484.11 |
| Price-to-Operating Cash Flow Ratio | 20.78 | 57.97 | 39.01 | 64.62 | 306.03 |
| Price-to-Earnings Growth (PEG) Ratio | -0.50 | -1.38 | 1.65 | 0.54 | 0.39 |
| Enterprise Value Multiple | 5.83 | 32.45 | 26.81 | 29.30 | 101.31 |
| Enterprise Value | 1.12B | 7.28B | 8.70B | 7.95B | 11.66B |
| EV to EBITDA | 5.83 | 32.45 | 26.81 | 29.30 | 101.31 |
| EV to Sales | 1.13 | 8.23 | 9.85 | 9.90 | 31.78 |
| EV to Free Cash Flow | 16.45 | 81.15 | 44.81 | 83.72 | 471.78 |
| EV to Operating Cash Flow | 14.05 | 53.05 | 36.51 | 61.38 | 298.23 |
| Tangible Book Value Per Share | 17.11 | 17.66 | 14.33 | 9.67 | 6.87 |
| Shareholders’ Equity Per Share | 83.74 | 94.63 | 85.32 | 83.39 | 84.38 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.33 | 0.17 | 0.13 | 0.10 | -0.31 |
| Revenue Per Share | 19.45 | 17.33 | 17.33 | 15.80 | 8.63 |
| Net Income Per Share | 1.31 | 2.58 | 4.59 | 3.70 | 2.03 |
| Tax Burden | 0.67 | 0.83 | 0.87 | 0.90 | 1.31 |
| Interest Burden | 0.92 | 0.97 | 1.00 | 0.91 | 0.74 |
| Research & Development to Revenue | 0.19 | 0.22 | 0.21 | 0.22 | 0.18 |
| SG&A to Revenue | 0.28 | 0.29 | 0.08 | 0.08 | 0.18 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.19 | 1.04 | 1.02 | 0.80 | 0.69 |
Currency in SEK

